Danaher Corp
DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$227.97−4.26 (-1.83%)
Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –
Danaher Diagnostics — Adjusted EBITDA: $944M in Q3 2026, up 13.9% from a year earlier.
Latest, Q3 2026
944
Period ended Sep 30, 2026
Change on a year earlier
+13.9%
829 in Q3 2025
History
19 quarters
Since Q1 2022
Sources
11
Documents cited below
Where the Q3 2026 figure comes from
Source: Danaher IR — nongaap_2026Q3 ↗
Reported in Danaher Non-GAAP Reconciliations & Supplemental Data (8-K / IR PDF).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Diagnostics — Adjusted EBITDA ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 944 | +13.9% | Danaher IR — nongaap_2026Q3 ↗ |
| Q2 2026 | Jun 30, 2026 | 712 | +1.4% | Danaher IR — nongaap_2026Q2 ↗ |
| Q1 2026 | Mar 31, 2026 | 841 | -2.9% | Danaher IR — nongaap_2026Q1 ↗ |
| Q4 2025 | Dec 31, 2025 | 856 | -1.8% | Danaher IR — nongaap_2025Q4 ↗ |
| Q3 2025 | Sep 30, 2025 | 829 | +9.2% | Danaher IR — nongaap_2026Q3 ↗ |
| Q2 2025 | Jun 30, 2025 | 702 | -0.3% | Danaher IR — nongaap_2026Q2 ↗ |
| Q1 2025 | Mar 31, 2025 | 866 | -11.2% | Danaher IR — nongaap_2026Q1 ↗ |
| Q4 2024 | Dec 31, 2024 | 872 | -6.7% | Danaher IR — nongaap_2025Q4 ↗ |
| Q3 2024 | Sep 30, 2024 | 759 | +11.5% | Danaher IR — nongaap_2025Q3 ↗ |
| Q2 2024 | Jun 30, 2024 | 704 | +23.5% | Danaher IR — nongaap_2025Q2 ↗ |
| Q1 2024 | Mar 31, 2024 | 975 | +18.9% | Danaher IR — nongaap_2025Q1 ↗ |
| Q4 2023 | Dec 31, 2023 | 935 | -17.8% | Danaher IR — nongaap_2024Q4 ↗ |
| Q3 2023 | Sep 30, 2023 | 681 | -25.1% | Danaher IR — nongaap_2024Q3 ↗ |
| Q2 2023 | Jun 30, 2023 | 570 | -39.9% | Danaher IR — nongaap_2024Q2 ↗ |
| Q1 2023 | Mar 31, 2023 | 820 | -20.7% | Danaher IR — nongaap_ex_veralto ↗ |
| Q4 2022 | Dec 31, 2022 | 1,138 | – | Danaher IR — nongaap_ex_veralto ↗ |
| Q3 2022 | Sep 30, 2022 | 909 | – | Danaher IR — nongaap_ex_veralto ↗ |
| Q2 2022 | Jun 30, 2022 | 948 | – | Danaher IR — nongaap_ex_veralto ↗ |
| Q1 2022 | Mar 31, 2022 | 1,034 | – | Danaher IR — nongaap_ex_veralto ↗ |
Cite this data
StockData. (2026). Danaher Diagnostics — Adjusted EBITDA ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/adj-ebitda-diag
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.